Background: Tumour-infiltrating lymphocytes (TILs) are often found in tumours, presumably
reflecting an immune response against the tumour. We carried out a systematic review and …

The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention
on tumor-infiltrating lymphocytes (TILs) across cancer types. The outcome of immune …

Myeloid-derived suppressor cells (MDSCs) contribute to tumor-mediated immune escape
and negatively correlate with overall survival of cancer patients. Nowadays, a variety of …

Antigen-presenting cells contain a specialized late endocytic compartment, MIIC (major
histocompatibility complex [MHC] class II-enriched compartment), that harbors newly …

PURPOSE The randomized Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in
Women With High-Risk Endometrial Cancer (PORTEC-3) trial investigated the benefit of …

Purpose: Recommendations for adjuvant treatment for women with early-stage endometrial
carcinoma are based on clinicopathologic features. Comprehensive genomic …

Background Although women with endometrial cancer generally have a favourable prognosis,
those with high-risk disease features are at increased risk of recurrence. The PORTEC-3 …

Purpose Ovarian cancer patients with intra-tumoral CD3 + T-lymphocytes in primary tumor
tissue have a better prognosis. This study aims to analyze the presence and relative influence …

This study aimed to investigate whether molecular analysis can be used to refine risk
assessment, direct adjuvant therapy, and identify actionable alterations in high-risk endometrial …

Background The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy
and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial …